Levetiracetam as first‐line monotherapy for Idiopathic Generalized Epilepsy in women

Abstract

LEV could be an effective drug as first-line treatment for IGE in women of childbearing potential. The adverse effects are its main limitation. Comparative studies are needed in order to establish it for this indication.